CXCL10 and cholestasis: In line with our hypothesis, that cholestasis could lead to a higher DPPIV serum activity and therefore higher antagonist form of IP-10 (cIP-10), three HCV patients with increased serum BA showed a trend toward higher frequency of CD3+CXCR3+ T cells in peripheral blood.